NanoViricides Inc. (NNVC)

[ZincFinger]

Because of the operative mechanism of nanoviricides, if they work in animals, they will work in people (just what part of "agnostic to the host" is causing your difficulty?)

The operative interation is entirely between the virus when outside cells and the drug. The receptors on the surface of the nanocides are the same as receptors in the host so the drug will not be attacked or affected by the host (except for a very tiny portion of the receptors on the drugs getting bound by the host molecules that usually bind to them. In the quantities that the drug will be used that will be a minuscule and insignificant percent of the receptors.)

This is not remotely the "big question mark" you are misportraying it as.

Drugs that work differently in people than in animals do so because differences in their biochemistries lead to differing interactions. But in THIS case there ARE no interactions with the host's biochemistry and therefore nothing to create differences between how the drug works in animals and humans. The drug is the same and the virus is the same so their interaction will be the same whether in animals or humans